Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Japan Tissue Engineering Co., Ltd. ( (JP:7774) ) has issued an update.
Japan Tissue Engineering Co., Ltd. reported a decline in financial performance for the six months ending September 30, 2025, with net sales dropping by 14% compared to the previous year. Despite the challenging financial results, the company maintains a strong equity to total assets ratio of 89.4%, indicating a stable financial position. The company has not declared any dividends for the fiscal year ending March 31, 2026, and has provided a range for its earnings forecasts due to external environmental factors affecting its business.
More about Japan Tissue Engineering Co., Ltd.
Japan Tissue Engineering Co., Ltd. operates in the biotechnology industry, focusing on the development and commercialization of regenerative medicine products. The company is listed on the Tokyo Stock Exchange and is known for its innovative tissue engineering solutions.
Average Trading Volume: 76,303
Technical Sentiment Signal: Sell
Current Market Cap: Yen19.53B
See more insights into 7774 stock on TipRanks’ Stock Analysis page.